Frank’s International N.V. Announces First Quarter 2017 Results
May 02, 2017 11:01 am UTC| Business
Revenue of $111 million, up 3% sequentially from the fourth quarter 2016U.S. onshore revenues up 16% sequentiallyStrong growth in West Africa and Latin America drove International segment revenues higher 2%...
Xplore Fulfills Follow-On Order for Ultra-Rugged Tablets from Leading Global Automotive Manufacturer
May 02, 2017 11:01 am UTC| Business
AUSTIN, Texas, May 02, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR) today announced that one of the world’s leading automotive manufacturers has equipped workers in one of its new U.S. body shops with Xplore’s...
Xplore Fulfills Follow-On Order for Ultra-Rugged Tablets from Leading Global Automotive Manufacturer
May 02, 2017 11:01 am UTC| Business
AUSTIN, Texas, May 02, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR) today announced that one of the world’s leading automotive manufacturers has equipped workers in one of its new U.S. body shops with Xplore’s...
Noble Energy Sells Upstream Appalachia Natural Gas Assets
May 02, 2017 11:01 am UTC| Business
Houston, May 02, 2017 -- Noble Energy, Inc. (NYSE: NBL) (“Noble Energy” or “the Company”) today announced that it has signed a definitive agreement to divest all of its upstream assets in northern West Virginia and...
Noble Energy Sells Upstream Appalachia Natural Gas Assets
May 02, 2017 11:01 am UTC| Business
Houston, May 02, 2017 -- Noble Energy, Inc. (NYSE: NBL) (“Noble Energy” or “the Company”) today announced that it has signed a definitive agreement to divest all of its upstream assets in northern West Virginia and...
May 02, 2017 11:01 am UTC| Business
BOSTON, May 02, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that an investigator-initiated Investigational New Drug (IND) application to the...
May 02, 2017 11:01 am UTC| Business
BOSTON, May 02, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that an investigator-initiated Investigational New Drug (IND) application to the...